Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension
- 21 September 2006
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 15 (10) , 1137-1139
Abstract
(2006). Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension. Expert Opinion on Investigational Drugs: Vol. 15, No. 10, pp. 1137-1139.Keywords
This publication has 20 references indexed in Scilit:
- Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic ratsKidney International, 2006
- ProreninHypertension, 2006
- Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic HypertensionHypertension, 2006
- Renin/prorenin receptorsKidney International, 2006
- Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanismsKidney International, 2006
- Renin, Prorenin and the Putative (Pro)renin ReceptorHypertension, 2005
- Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARBKidney International, 2002
- Enalapril Attenuates Oxidative Stress in Diabetic RatsHypertension, 2001
- Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetesJournal of Clinical Investigation, 2001
- Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.Journal of Clinical Investigation, 1996